• Flash Briefings and Podcasts

  First Patient Treated in The Phase 2/3 Trial, Assessing Higher Doses of Spinraza

  Posted by sma-news-today-moderator on April 24, 2020 at 7:05 am

  

  Forums Director Kevin Schaefer writes about a new at-home exercise routine he’s developed, using his electric ceiling lift.

  SMA News Today’s multimedia associate, Price Wooldridge, discusses the first patient treated in the Phase 2/3 trial, assessing higher doses of Spinraza.

  https://soundcloud.com/sma-news-today/first-patient-treated-in-the-phase-23-trial-assessing-higher-doses-of-spinraza

  Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

  sma-news-today-moderator replied 5 years, 2 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply